Skip to main content
. 2021 Dec 7;1(3):385–395. doi: 10.1016/j.jacasi.2021.09.005

Figure 4.

Figure 4

The Prognosis of Clinical CS During Each Cardiac Function

The Kaplan-Meier curves reveal the frequency of (A) all-cause death–free and (B) adverse event–free survival in clinical cardiac sarcoidosis (CS) patients during each cardiac function. The Kaplan-Meier curves reveal the frequency of (C) all-cause death–free and (D) adverse event–free survival in histological CS patients during each cardiac function. The blue line indicates left ventricular ejection fraction (LVEF) ≥50%, the green line indicates 35% < LVEF <50%, and the red line indicates LVEF ≤35%).